Late Breaking Abstract- Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)

被引：1
|
作者：
Ali, Nasloon [1 ]
Lyu, Juntao [1 ]
Newell, Anthony [1 ]
Sadatsafavi, Mohsen [2 ]
Tran, Trung N. [3 ]
Price, David B. [1 ,4 ]
机构：
[1] Observat & Pragmat Res Inst, Singapore, Singapore
[2] Univ British Columbia, Fac Pharmaceut Sci, Resp Evaluat Sci Program, Vancouver, BC, Canada
[3] AstraZeneca, Gaithersburg, MD USA
[4] Univ Aberdeen, Div Appl Hlth Sci, Ctr Acad Primary Care, Aberdeen, Scotland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 58卷
关键词：
Treatments; Severe asthma; Asthma; -; management;
D O I：
10.1183/13993003.congress-2021.PA1113
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1113
引用
收藏
页数：2
相关论文
共 45 条
  • [31] Anti-IL5 and anti-IL5R-alpha Therapy in Patients with clinically significant Bronchiectasis and an eosinophilic Endotype: a retrospective Case Series
    Rademacher, J.
    Konwert, S.
    Fuge, J.
    Dettmer, S.
    Welte, T.
    Ringshausen, F. C.
    PNEUMOLOGIE, 2020, 74 : S7 - S7
  • [32] Sputum cell counts and FeNO levels in patients treated with anti-IgE and anti-IL-5 /IL-5R: Evidence for a dissociation between sputum eosinophil counts and FeNO levels
    Sabbe, Mare
    Schleich, Florence
    Bougard, Nicolas
    Moermans, Catherine
    Henquet, Monique
    Guissard, Francoise
    Sanschez, Carole
    Paulus, Virginie
    Louis, Renaud
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [33] Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?
    Laroche, Jeremy
    Pelletier, Genevieve
    Boulay, Marie-Eve
    Cote, Andreanne
    Godbout, Krystelle
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 755 - 763
  • [34] A FENO-BASED STRATEGY TO GUIDE ORAL CORTICOSTEROID INITIATION IN PATIENTS WITH SEVERE ASTHMA EXPERIENCING AN EXACERBATION WHILST ON TREATMENT WITH ANTI-IL5/5R THERAPY
    Lam, J. L.
    Hearn, A. P.
    Thomson, L. A.
    Green, L. M.
    Fernandes, M.
    Roxas, C.
    D'Ancona, G.
    Dhariwal, I.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2022, 77 : A87 - A87
  • [35] Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma
    Gates, Jessica
    Hearn, Andrew
    Mason, Tom
    Fernandes, Mariana
    Green, Linda
    Thomson, Louise
    Roxas, Cris
    Lam, Jodie
    d'Ancona, Grainne
    Nanzer, Alexandra M.
    Dhariwal, Jaideep
    Jackson, David J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (07): : 1794 - 1800
  • [36] Real-world effectiveness of anti-IL-5/5R therapy in severe eosinophilic asthma with comorbid bronchiectasis
    van Nederveen-Bendien, S. A.
    Kroes, H.
    Maitland-Van Der Zee, A.
    Ten Brinke, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [37] Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study
    Barroso, B.
    Valverde-Monge, M.
    Alobid, I
    Olaguibel, J. M.
    Rial, M. J.
    Quirce, S.
    Arismendi, E.
    Barranco, P.
    Betancor, D.
    Bobolea, I
    Cardaba, B.
    Carmona, Cruz M. J.
    Curto, E.
    Dominguez-Ortega, J.
    Gonzalez-Barcala, F.
    Martinez-Rivera, C.
    Mahillo-Fernandez, I
    Munoz, X.
    Picado, C.
    Plaza, V
    Munoz, Rodrigo J. M.
    Soto-Retes, L.
    Valero, A.
    del Pozo, V
    Mullol, J.
    Sastre, J.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (01) : 37 - 44
  • [38] Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma
    Van Hulst, Glenn
    Jorssen, Joseph
    Jacobs, Nathalie
    Henket, Monique
    Louis, Renaud
    Schleich, Florence
    Bureau, Fabrice
    Desmet, Christophe
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [39] Differential PTGDR2 Expression In Blood Cell Populations From Asthmatic Patients After Treatment With Anti-IL5 Or Anti-IL4R
    Martin, Maria
    Estravis, Miguel
    Garcia-Sanchez, Asuncion
    Perez-Pazos, Jaqueline
    Martin-Garcia, Cristina
    Davila, Ignacio
    Sanz, Catalina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB326 - AB326
  • [40] Late Breaking Abstract - Anti-IL-5 therapy is associated with sustained improvement in FEV1 in severe eosinophilic asthma patients.
    Blekic, Nathan
    Van Muylem, Alain
    Makhoul, Jean-Pierre
    Haccuria, Amaryllis
    Malinovschi, Andrei
    Michils, Alain
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345